BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34582671)

  • 41. Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
    Chen B; Ji M; Li P; Liu P; Zou W; Zhao Z; Qu B; Li Z; Bin X; Lang J; Wang H; Chen C
    Gynecol Oncol; 2020 May; 157(2):429-436. PubMed ID: 32067814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Moving beyond the Cox proportional hazards model in survival data analysis: a cervical cancer study.
    Li L; Yang Z; Hou Y; Chen Z
    BMJ Open; 2020 Jul; 10(7):e033965. PubMed ID: 32690495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
    Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
    Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A survival study of uterine cervical patients in the North East India: Hospital-cancer registry-based analysis.
    Kataki AC; Sharma JD; Krishnatreya M; Baishya N; Barmon D; Deka P; Kalita M
    J Cancer Res Ther; 2018; 14(5):1089-1093. PubMed ID: 30197354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer.
    Xie S; Pan S; Zou S; Zhu H; Zhu X
    Clin Interv Aging; 2020; 15():841-851. PubMed ID: 32606624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small cell carcinoma of the uterine cervix: a multi-institutional experience.
    Li J; Ouyang Y; Tao Y; Wang L; Li M; Gao L; Cao X
    Int J Gynecol Cancer; 2020 Feb; 30(2):174-180. PubMed ID: 31792086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
    Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
    Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between changes in the number of peripheral blood lymphocytes and survival rate in patients with cervical cancer after radio-chemotherapy.
    Han X; Yang Q; Zhang J; Cao J
    Cancer Radiother; 2021 Feb; 25(1):72-76. PubMed ID: 33414058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
    Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
    Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy Improves the Survival of Patients With Metastatic Cervical Cancer: A Propensity-Matched Analysis of SEER Database.
    Huang K; Jia M; Li P; Han J; Zhang R; Li Q; Qiao Y; Xu T; Ruan P; Song Q; Li Y; Fu Z
    Int J Gynecol Cancer; 2018 Sep; 28(7):1360-1368. PubMed ID: 30036221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Taarnhøj GA; Christensen IJ; Lajer H; Fuglsang K; Jeppesen MM; Kahr HS; Høgdall C
    Cancer; 2018 Mar; 124(5):943-951. PubMed ID: 29211304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort.
    Endo D; Todo Y; Okamoto K; Minobe S; Kato H; Nishiyama N
    J Gynecol Oncol; 2015 Jan; 26(1):12-8. PubMed ID: 25310853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of distant relapse in patients with FIGO stage IIB-IVA cervical cancer treated with definitive radiotherapy.
    Okazawa-Sakai M; Mabuchi S; Isohashi F; Kawashima A; Yokoi E; Ogawa K; Kimura T
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1743-1750. PubMed ID: 28816403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
    Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.